236 related articles for article (PubMed ID: 9356311)
1. Additive estrogenic activities of a binary mixture of 2',4',6'-trichloro- and 2',3',4',5'-tetrachloro-4-biphenylol.
Ramamoorthy K; Vyhlidal C; Wang F; Chen I; Safe S; McDonnell DP; Leonard LS; Gaido KW
Toxicol Appl Pharmacol; 1997 Nov; 147(1):93-100. PubMed ID: 9356311
[TBL] [Abstract][Full Text] [Related]
2. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
[TBL] [Abstract][Full Text] [Related]
3. Hydroxylated polychlorinated biphenyls (PCBs) as estrogens and antiestrogens: structure-activity relationships.
Connor K; Ramamoorthy K; Moore M; Mustain M; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jul; 145(1):111-23. PubMed ID: 9221830
[TBL] [Abstract][Full Text] [Related]
4. Examination of the estrogenicity of 2,4,6,2',6'-pentachlorobiphenyl (PCB 104), its hydroxylated metabolite 2,4,6,2',6'-pentachloro-4-biphenylol (HO-PCB 104), and a further chlorinated derivative, 2,4,6,2',4',6'-hexachlorobiphenyl (PCB 155).
Fielden MR; Chen I; Chittim B; Safe SH; Zacharewski TR
Environ Health Perspect; 1997 Nov; 105(11):1238-48. PubMed ID: 9370515
[TBL] [Abstract][Full Text] [Related]
5. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
[TBL] [Abstract][Full Text] [Related]
6. Antiestrogenic activity of hydroxylated polychlorinated biphenyl congeners identified in human serum.
Moore M; Mustain M; Daniel K; Chen I; Safe S; Zacharewski T; Gillesby B; Joyeux A; Balaguer P
Toxicol Appl Pharmacol; 1997 Jan; 142(1):160-8. PubMed ID: 9007045
[TBL] [Abstract][Full Text] [Related]
7. Ligand structure-dependent differences in activation of estrogen receptor alpha in human HepG2 liver and U2 osteogenic cancer cell lines.
Yoon K; Pellaroni L; Ramamoorthy K; Gaido K; Safe S
Mol Cell Endocrinol; 2000 Apr; 162(1-2):211-20. PubMed ID: 10854714
[TBL] [Abstract][Full Text] [Related]
8. Differential activation of wild-type and variant forms of estrogen receptor alpha by synthetic and natural estrogenic compounds using a promoter containing three estrogen-responsive elements.
Yoon K; Pallaroni L; Stoner M; Gaido K; Safe S
J Steroid Biochem Mol Biol; 2001 Jul; 78(1):25-32. PubMed ID: 11530281
[TBL] [Abstract][Full Text] [Related]
9. Naringenin: a weakly estrogenic bioflavonoid that exhibits antiestrogenic activity.
Ruh MF; Zacharewski T; Connor K; Howell J; Chen I; Safe S
Biochem Pharmacol; 1995 Oct; 50(9):1485-93. PubMed ID: 7503800
[TBL] [Abstract][Full Text] [Related]
10. Lack of synergy by mixtures of weakly estrogenic hydroxylated polychlorinated biphenyls and pesticides.
Arcaro KF; Vakharia DD; Yang Y; Gierthy JF
Environ Health Perspect; 1998 Aug; 106 Suppl 4(Suppl 4):1041-6. PubMed ID: 9703490
[TBL] [Abstract][Full Text] [Related]
11. Failure of chloro-S-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro.
Connor K; Howell J; Chen I; Liu H; Berhane K; Sciarretta C; Safe S; Zacharewski T
Fundam Appl Toxicol; 1996 Mar; 30(1):93-101. PubMed ID: 8812239
[TBL] [Abstract][Full Text] [Related]
12. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
[TBL] [Abstract][Full Text] [Related]
13. Problems for risk assessment of endocrine-active estrogenic compounds.
Safe SH; Pallaroni L; Yoon K; Gaido K; Ross S; McDonnell D
Environ Health Perspect; 2002 Dec; 110 Suppl 6(Suppl 6):925-9. PubMed ID: 12634121
[TBL] [Abstract][Full Text] [Related]
14. Estrogenic effects of 7alpha-methyl-17alpha-ethynylestradiol: a newly discovered tibolone metabolite.
Bodine PV; Harris HA; Lyttle CR; Komm BS
Steroids; 2002 Jul; 67(8):681-6. PubMed ID: 12117614
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo interactions of bisphenol A and its metabolite, bisphenol A glucuronide, with estrogen receptors alpha and beta.
Matthews JB; Twomey K; Zacharewski TR
Chem Res Toxicol; 2001 Feb; 14(2):149-57. PubMed ID: 11258963
[TBL] [Abstract][Full Text] [Related]
16. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.
Kuiper GG; Lemmen JG; Carlsson B; Corton JC; Safe SH; van der Saag PT; van der Burg B; Gustafsson JA
Endocrinology; 1998 Oct; 139(10):4252-63. PubMed ID: 9751507
[TBL] [Abstract][Full Text] [Related]
17. ER-dependent estrogenic activity of parabens assessed by proliferation of human breast cancer MCF-7 cells and expression of ERalpha and PR.
Okubo T; Yokoyama Y; Kano K; Kano I
Food Chem Toxicol; 2001 Dec; 39(12):1225-32. PubMed ID: 11696396
[TBL] [Abstract][Full Text] [Related]
18. 17 beta-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context.
Castro-Rivera E; Safe S
J Steroid Biochem Mol Biol; 2003 Jan; 84(1):23-31. PubMed ID: 12648521
[TBL] [Abstract][Full Text] [Related]
19. Assessment of polystyrene extract for estrogenic activity in the rat uterotrophic model and an in vitro recombinant receptor reporter gene assay.
Fail PA; Hines JW; Zacharewski T; Wu ZF; Borodinsky L
Drug Chem Toxicol; 1998; 21 Suppl 1():101-21. PubMed ID: 10028405
[TBL] [Abstract][Full Text] [Related]
20. 2,2',4,4',5,5'- and 3,3',4,4',5,5'-hexachlorobiphenyl alteration of uterine progesterone and estrogen receptors coincides with embryotoxicity in mink (Mustela vision).
Patnode KA; Curtis LR
Toxicol Appl Pharmacol; 1994 Jul; 127(1):9-18. PubMed ID: 8048058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
